Home > PS Ratio > AJANTA PHARMA

AJANTA PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of AJANTA PHARMA is 7.38.

Share Price ₹2,676.1Jan 30,2025
Market Cap ₹33,423.9 Cr
Sales-TTM₹4,531.8 CrTTM-Consolidated Results
Price/Sales7.38xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of AJANTA PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of AJANTA PHARMA is calculated as :

Current Market Cap [ ₹33,423.9 Cr] as on Jan 30,2025

(/) Sales [ ₹4,531.8 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 7.38x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for AJANTA PHARMA , the investors are currently willing to pay '7.38 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of AJANTA PHARMA !

The chart below summarizes the trend in P/S Ratio of AJANTA PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of AJANTA PHARMA


PS Ratio Performance Analysis for AJANTA PHARMA

- AJANTA PHARMA 's latest p/e ratio is 7.38x.

- AJANTA PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.07x.

- AJANTA PHARMA 's operated at median p/e ratio of 4.62x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AJANTA PHARMA 's p/e ratio peaked in Mar2024 at 6.7x.

- AJANTA PHARMA 's p/e ratio hit its five-year low in Mar2023 of 4.07x.


How does AJANTA PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
AJANTA PHARMA 4,531.87.3833,423.9
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.32418,744.0
CIPLA LTD26,981.24.36117,762.0
DR REDDYS LABORATORIES LTD31,229.33.1999,705.3
ZYDUS LIFESCIENCES LTD21,483.54.4795,929.3
DIVIS LABORATORIES LTD8,614.017.67152,209.0
MANKIND PHARMA LTD11,641.08.82102,663.0
TORRENT PHARMACEUTICALS LTD11,302.010.05113,621.0
LUPIN LTD21,431.34.4094,191.9
AUROBINDO PHARMA LTD30,295.02.2768,671.1
ABBOTT INDIA LTD6,066.19.1455,449.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AJANTA PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.27x
Max industry PS 17.67x
Median industry PS 7.38x
Average industry PS 7.28x



You may also like the below Video Courses